Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs.
Elevation of 20-carbon long chain bases due to a mutation in serine palmitoyltransferase small subunit b results in neurodegeneration.
Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice.
Frequency, characteristics and consequences of falls in multiple sclerosis: findings from a cohort study.
[Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice.]
Multiple sclerosis: Reprogramming the immune repertoire with alemtuzumab in MS.
Chronic Peripheral Inflammation, Hippocampal Neurogenesis, and Behavior.
Neurogenic Causes of Detrusor Underactivity.
Heterogeneous spectrum of neuropathies in Waldenström's macroglobulinemia: a diagnostic strategy to optimize their management.
Multiple sclerosis drugs: Sticker shock.
A systematic review of stress-management interventions for multiple sclerosis patients.
Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study.
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal Ig synthesis in Multiple Sclerosis patients.
Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
Fecundity in women with multiple sclerosis: an observational mono-centric study.
Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Chronic Inflammatory Pure Sensory Polyradiculoneuropathy: A Rare CIDP Variant With Unusual Electrophysiology.
The Role of Astrocytes in Multiple Sclerosis Progression.
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
Examination of the Chicago Multiscale Depression Inventory and Initial Validation of a Positive Scale.
Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease.
Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait.
Adjudin - a Male Contraceptive with Other Biological Activities.
Cyclin-Dependent Kinase 5 Mediates Adult OPC Maturation and Myelin Repair through Modulation of Akt and GsK-3β Signaling.
Pages
« first
‹ previous
…
651
652
653
654
655
656
657
658
659
…
next ›
last »